Visual Disturbance in Multiple Sclerosis: The Effect of Tinted Spectacle Lenses
Journal of Ophthalmic and Optometric Sciences,
Vol. 9 No. 1 (2025),
21 December 2024
,
Page 49-53
https://doi.org/10.22037/joos.v9i1.49712
Abstract
This case report investigates the impact of tinted spectacle lenses on visual disturbances in a patient with multiple sclerosis (MS). A 42-year-old woman with preclinical-stage MS presented with severe photophobia and visual discomfort, despite normal visual acuity and the absence of ocular pathology. Conventional spectacles had failed to alleviate her symptoms. The patient reported marked improvement in visual comfort, reduced photophobia, and better tolerance to daily visual environments one month after being prescribed yellow-tinted lenses with medium density (category B). This case supports the potential utility of tinted lenses as a non-invasive, optical intervention for managing visual symptoms in MS. Further studies are warranted to assess the efficacy of various lens colors and densities across a broader spectrum of neurological disorders with visual complaints.
- Multiple Sclerosis
- Photophobia
- Tinted Lenses
- Visual Disturbance
How to Cite
References
Wilkins AJ, Haigh SM, Mahroo OA, Plant GT. Photophobia in migraine: A symptom cluster? Cephalalgia. 2021;41(11-12):1240-8.
Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol. 2012;32(1):68-81.
Wu Y, Hallett M. Photophobia in neurologic disorders. Transl Neurodegener. 2017;6:26.
Matynia A, Parikh S, Chen B, Kim P, McNeill DS, Nusinowitz S, et al. Intrinsically photosensitive retinal ganglion cells are the primary but not exclusive circuit for light aversion. Exp Eye Res. 2012;105:60-9.
Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 2018;97(4):742-68.
Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA. "Seeing" in NARCOMS: a look at vision-related quality of life in the NARCOMS registry. Mult Scler. 2013;19(7):953-60.
Garcia-Martin E, Rodriguez-Mena D, Herrero R, Almarcegui C, Dolz I, Martin J, et al. Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS. Neurology. 2013;81(1):76-83.
McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992;55(9):747-52.
Jasse L, Vukusic S, Durand-Dubief F, Vartin C, Piras C, Bernard M, et al. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability. Mult Scler. 2013;19(12):1618-26.
van der Feen FE, de Haan GA, van der Lijn I, Huizinga F, Meilof JF, Heersema DJ, et al. Recognizing visual complaints in people with multiple sclerosis: Prevalence, nature and associations with key characteristics of MS. Mult Scler Relat Disord. 2022;57:103429.
Hepworth L, Rowe F, Walker M, Rockliffe J, Noonan C, Howard C, et al. Post-stroke Visual Impairment: A Systematic Literature Review of Types and Recovery of Visual Conditions. Ophthalmology Research: An International Journal. 2016;5(1):1-43.
Armstrong RA. Visual problems associated with traumatic brain injury. Clin Exp Optom. 2018;101(6):716-26.
Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA. “Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry. Mult Scler J. 2013;19(7):953-60.
Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review. Neuroepidemiology. 2016;46(3):209-21.
Brundin L, Kobelt G, Berg J, Capsa D, Eriksson J; European Multiple Sclerosis Platform. New insights into the burden and costs of multiple sclerosis in Europe: Results for Sweden. Mult Scler. 2017;23(2_suppl):179-91.
Langelaan M, de Boer MR, van Nispen RM, Wouters B, Moll AC, van Rens GH. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol. 2007;14(3):119-26.
Hickman SJ, Raoof N, McLean RJ, Gottlob I. Vision and multiple sclerosis. Mult Scler Relat Disord. 2014;3(1):3-16.
Noble J, Forooghian F, Sproule M, Westall C, O'Connor P. Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients. Am J Ophthalmol. 2006;142(3):464-8.
Hoff JM, Dhayalan M, Midelfart A, Tharaldsen AR, Bø L. Visual dysfunction in multiple sclerosis. Tidsskr Nor Laegeforen. 2019;139(11).
Costello F. Vision Disturbances in Multiple Sclerosis. Semin Neurol. 2016;36(2):185-95.
Francis CE. Visual issues in multiple sclerosis. Phys Med Rehabil Clin N Am. 2013;24(4):687-702.
Balcer LJ, Miller DH, Reingold SC, Cohen JA. Vision and vision-related outcome measures in multiple sclerosis. Brain. 2015;138(Pt 1):11-27.
Yadav NK, Ciuffreda KJ. Objective assessment of visual attention in mild traumatic brain injury (mTBI) using visual-evoked potentials (VEP). Brain Inj. 2015;29(3):352-65.
Ciuffreda KJ, Yadav NK, Ludlam DP. Effect of binasal occlusion (BNO) on the visual-evoked potential (VEP) in mild traumatic brain injury (mTBI). Brain Inj. 2013;27(1):41-7.
Wilkins A, Evans B, Plant G. Potential Uses for Precision Tinted Lenses in a Neurology Clinic. touchREVIEWS in Neurology. 2022;18(2):93-102.
Mehta M, Ramkissoon P, Bhagwanjee A. A comparison of the effect of reduced illumination and tinted lenses on stereopsis at near. African Vision and Eye Health. 2007;66(1):3-11.
Marmor MF. Double fault! Ocular hazards of a tennis sunglass. Arch Ophthalmol. 2001;119(7):1064-6.
Seelan Samuel S, Pachiyappan T, Livingstone Kumaran S. Impact of Tinted Lenses on Contrast Sensitivity, Color Vision, and Visual Reaction Time in Young Adults. Cureus. 2023;15(11):e48377.
- Abstract Viewed: 110 times
- pdf Downloaded: 92 times
